[

pfizer inc

]
The mutation could be responsible for greater transmissibility and there had been concern it could also make the virus escape antibody neutralization elicited by the vaccine, said Phil Dormitzer, one of Pfizer’s top viral vaccine scientists.(Reuters image)

Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants: Study

By Reuters | Posted by Prashasti Singh | New York
UPDATED ON JAN 08, 2021 09:07 AM IST
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
Close
Dr Balram Bhargava on Sunday said Covaxin might be more effective to fight the new strain of virus.(ANI)
Dr Balram Bhargava on Sunday said Covaxin might be more effective to fight the new strain of virus.(ANI)

‘2 vaccines a result proactive approach,’ says DG-ICMR

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 04, 2021 05:48 AM IST
“These kinds of approvals are purely data-driven, and in both these vaccines Phase 2 immunogenicity has been well established. The question of approving a vaccine without adequate data does not arise as the expert panel minutely scans the national as well international data presented to them before granting an approval,” said DG-ICMR.
Close
A nurse prepares a Pfizer COVID-19 vaccine to be administered to elderly people in Soroka Hospital in Beersheba, Israel, Tuesday, Dec. 29, 2020. (AP Photo/Tsafrir Abayov)
A nurse prepares a Pfizer COVID-19 vaccine to be administered to elderly people in Soroka Hospital in Beersheba, Israel, Tuesday, Dec. 29, 2020. (AP Photo/Tsafrir Abayov)

Covid-19 vaccination: Singapore, Ireland commence immunisation drives

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 30, 2020 10:30 AM IST
Iran has started its first study of the safety and effectiveness of a Covid-19 vaccine, a locally developed candidate.
Close
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo(REUTERS)
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo(REUTERS)

Covid-19 vaccine update: Gennova Pharmaceuticals gets permission for trials, US deems Moderna candidate safe for use

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 16, 2020 07:48 AM IST
Oman has joined the list of countries to allow the use of Pfizer’s vaccine candidate. Indonesia, meanwhile, is planning to vaccinate its young people before senior citizens.
Close
Gina Harper, clinical coordinator with the pharmacy, measures out the exact amount of the Covid-19 vaccine for a dose before it is administered to the first patients in Colorado at UCHealth Poudre Valley Hospital, Monday, Dec. 14, 2020, in Fort Collins, Colo. (Helen H. Richardson/The Denver Post via AP)
Gina Harper, clinical coordinator with the pharmacy, measures out the exact amount of the Covid-19 vaccine for a dose before it is administered to the first patients in Colorado at UCHealth Poudre Valley Hospital, Monday, Dec. 14, 2020, in Fort Collins, Colo. (Helen H. Richardson/The Denver Post via AP)

Covid-19 vaccine update: US begins vaccination drive, Russia claims its Sputnik V over 91% effective

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 15, 2020 07:47 AM IST
Israel’s defence ministry has said the Israel Institute for Biological Research (IIBR) has “successfully completed” phase one of the domestic Covid-19 vaccine trials and plans to start phase two “in the coming days.”
Close
The doses will go to 14 sites around Canada, with the most vulnerable first in line for shots.(REUTERS)
The doses will go to 14 sites around Canada, with the most vulnerable first in line for shots.(REUTERS)

Canada expects first Pfizer/BioNTEch Covid-19 vaccines to arrive Sunday

By Reuters | Posted by Kunal Gaurav | Ottawa
PUBLISHED ON DEC 13, 2020 10:58 PM IST
As early as Monday, Canada and the United States are set to become the first Western nations after the UK to begin inoculations with the vaccine developed by Pfizer Inc and Germany’s BioNTech SE.
Close
The US authorized the first Covid-19 vaccine developed by Pfizer Inc and BioNTech SE , making it available for emergency use to patients aged 16 and older.(Reuters/ Representational)
The US authorized the first Covid-19 vaccine developed by Pfizer Inc and BioNTech SE , making it available for emergency use to patients aged 16 and older.(Reuters/ Representational)

US has authorized the first Covid-19 vaccine. What happens next?

By hindustantimes.com| Edited by Mallika Soni | Hindustan Times, New Delhi
PUBLISHED ON DEC 12, 2020 10:15 AM IST
The federal government plans to release the nation’s first 2.9 million doses within days of the authorization to 64 states, US territories and major cities, as well as five federal agencies.
Close
A medic administers COVAXIN, an Indian government-backed experimental COVID-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad.(REUTERS)
A medic administers COVAXIN, an Indian government-backed experimental COVID-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad.(REUTERS)

US FDA nod may give Pfizer’s approval case in India a boost

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON DEC 12, 2020 07:32 AM IST
So far, the Indian regulator has not granted regulatory approvals to any vaccine candidate based on data generated during trials held in other countries.
Close
A man receives the first of two Pfizer/BioNTech COVID-19 vaccine jabs, at Guy's Hospital, at the start of the largest ever immunisation programme in the British history, in London, Britain.(REUTERS)
A man receives the first of two Pfizer/BioNTech COVID-19 vaccine jabs, at Guy's Hospital, at the start of the largest ever immunisation programme in the British history, in London, Britain.(REUTERS)

Where are we in the Covid-19 vaccine race?

By Reuters | Posted by Shivani Kumar | Reuters
UPDATED ON DEC 11, 2020 09:16 PM IST
The coronavirus pandemic has killed as many as 1.6 million people worldwide.
Close
Prime Minister Narendra Modi addressing the inaugural session of India Mobile Congress 2020 virtually through video conferencing in New Delhi on Tuesday.(ANI)
Prime Minister Narendra Modi addressing the inaugural session of India Mobile Congress 2020 virtually through video conferencing in New Delhi on Tuesday.(ANI)

Mobile technology will aid India’s Covid vaccination drive, says PM Modi

By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON DEC 08, 2020 12:33 PM IST
PM Modi urged the younger generation to keep innovating and also highlighted the crucial role technology played in the handling of the coronavirus pandemic.
Close
Pfizer Inc had already applied for emergency use approval for its vaccine in India over the weekend, the official said, declining to be identified.(REUTERS)
Pfizer Inc had already applied for emergency use approval for its vaccine in India over the weekend, the official said, declining to be identified.(REUTERS)

India speeding up review of Pfizer, Astra Covid-19 vaccines: Official

By Reuters | Posted by Shivani Kumar | New Delhi
UPDATED ON DEC 07, 2020 11:11 PM IST
The Indian government is pinning its hopes for mass supply of the vaccine on Serum Institute of India, the world’s largest vaccine producer by volume, which on Monday lodged the first formal application for emergency use approval for AstraZeneca Plc’s Covid-19 vaccine.
Close
A Food and Drug Administration panel of outside advisers will meet on December 10 to discuss whether to recommend emergency use authorization of the Pfizer vaccine. They are expected to review Moderna’s candidate a week later.(REUTERS (Representative image))
A Food and Drug Administration panel of outside advisers will meet on December 10 to discuss whether to recommend emergency use authorization of the Pfizer vaccine. They are expected to review Moderna’s candidate a week later.(REUTERS (Representative image))

US to prepare for swift vaccine roll out as Covid cases surge

By Reuters | Posted by Nilavro Ghosh | Washington
UPDATED ON DEC 02, 2020 07:15 AM IST
Some 60 million to 70 million doses of Covid-19 vaccine could be available per month beginning in January, after the expected regulatory approval of products from Pfizer Inc and Moderna Inc.
Close
US drugmaker Pfizer and Germany’s BioNTech reported final trial results on November 18.(REUTERS)
US drugmaker Pfizer and Germany’s BioNTech reported final trial results on November 18.(REUTERS)

Pfizer-BioNTech apply for EU emergency authorization for Covid-19 vaccine

By Reuters | Posted by Kunal Gaurav | Frankfurt
PUBLISHED ON DEC 01, 2020 03:51 PM IST
The application to the European Medicines Agency (EMA) comes after the companies applied for US approval on Nov. 20, taking them a step closer to launching their vaccine.
Close
The US Food and Drug Administration said an advisory committee would meet to discuss the request on Dec. 17.(AP)
The US Food and Drug Administration said an advisory committee would meet to discuss the request on Dec. 17.(AP)

Moderna files for US vaccine authorization, will seek EU nod

By Reuters | Posted by Prashasti Singh
UPDATED ON DEC 01, 2020 06:46 AM IST
A shot developed by Pfizer Inc and BioNTech SE that was 95% effective in its pivotal trial is set to be reviewed by a panel of outside experts a week earlier. The FDA will decide on the emergency use authorizations (EUA)after the advisers make their recommendations.
Close
Organisations- both at the private and government level are rushing towards developing a full-proof vaccine to combat Covid-19 with minimum or no side effects.(AP file photo. Representative image)
Organisations- both at the private and government level are rushing towards developing a full-proof vaccine to combat Covid-19 with minimum or no side effects.(AP file photo. Representative image)

Covid-19 vaccine updates: UK to purchase over 350 mn doses, US likely to see vaccine roll out before Dec end

By hindustantimes.com| Edited by: Harshit Sabarwal | Hindustan Times, New Delhi
UPDATED ON NOV 30, 2020 08:25 AM IST
The UK is poised to become the first country to approve the vaccine developed by Pfizer Inc and BioNTech SE. The government had already indicated that it would move fast on any promising vaccine candidate and British doctors have been put on standby for a possible roll out before Christmas
Close
Pfizer, Moderna and AstraZeneca have already started manufacturing their vaccines.(File photo for representation)
Pfizer, Moderna and AstraZeneca have already started manufacturing their vaccines.(File photo for representation)

Explained: When and how will Covid-19 vaccines become available around the world?

By Reuters | Posted by Niyati Singh | New York
UPDATED ON NOV 25, 2020 08:20 PM IST
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their Covid-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90% effective.
Close
FILE PHOTO: Trailers are shown in a city parking lot after a Phase 3 trial location of Johnson & Johnson's Janssen (COVID-19) vaccine candidate was announced in National City during the outbreak of the coronavirus disease (COVID-19) in National City, California, U.S., October 13, 2020. REUTERS/Mike Blake(REUTERS)
FILE PHOTO: Trailers are shown in a city parking lot after a Phase 3 trial location of Johnson & Johnson's Janssen (COVID-19) vaccine candidate was announced in National City during the outbreak of the coronavirus disease (COVID-19) in National City, California, U.S., October 13, 2020. REUTERS/Mike Blake(REUTERS)

Covid-19 vaccine update: India to immunise 250 million citizens, US vaccinations might begin in December

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON NOV 23, 2020 01:42 PM IST
The United Kingdom could give approval to Pfizer’s vaccine candidate this week, a report claimed. Meanwhile, the official Twitter account of Russia’s vaccine candidate Sputnik V claimed the price per dose of the vaccine would be “much lower” than that of Moderna and Pfizer’s vaccine candidates.
Close
The U.S. Food and Drug Administration said on Friday that it would meet on Dec. 10 to discuss whether to authorise the vaccine.(REUTERS)
The U.S. Food and Drug Administration said on Friday that it would meet on Dec. 10 to discuss whether to authorise the vaccine.(REUTERS)

Pfizer Covid-19 vaccine could get UK approval this week: Report

By Reuters | Posted by Shivani Kumar | London
UPDATED ON NOV 23, 2020 02:41 AM IST
Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by Dec. 1.
Close
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic

Covid-19 vaccine updates: Bharat Biotech to recruit volunteers for trial, Pfizer files for emergency use authorisation

By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON NOV 21, 2020 08:13 AM IST
Britain’s AstraZeneca has launched phase three trials of an antibody combination drug, called AZD7442, that it hopes could be used to protect those at risk of contracting the coronavirus disease for up to 12 months.
Close
Gold has risen about 23% this year amid unprecedented global stimulus during the pandemic, given its status as a hedge against likely inflation and currency debasement resulting from the measures.(Reuters file photo)
Gold has risen about 23% this year amid unprecedented global stimulus during the pandemic, given its status as a hedge against likely inflation and currency debasement resulting from the measures.(Reuters file photo)

Gold gains on stimulus bets, concerns over vaccine rollout

By Reuters | Posted by Deepali Sharma | Reuters
UPDATED ON NOV 12, 2020 09:32 PM IST
Gold prices are still down about 4.1% so far this week after Monday’s encouraging late-stage vaccine trial data from Pfizer Inc powered a surge in equities and drove a sharp retreat in safe-haven bullion.
Close
The study comes as Pfizer Inc on Monday said its experimental Covid-19 vaccine is more than 90% effective based on interim data from late stage trials.(Reuters)
The study comes as Pfizer Inc on Monday said its experimental Covid-19 vaccine is more than 90% effective based on interim data from late stage trials.(Reuters)

Study says misinformation could prompt people to turn against Covid-19 vaccines

By Reuters | Posted by Deepali Sharma | London
PUBLISHED ON NOV 12, 2020 09:31 PM IST
Women were more likely than men to refuse a Covid-19 vaccine, but more respondents said they would accept a vaccine if it meant protecting family, friends, or at-risk groups.
Close
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany.(REUTERS)
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany.(REUTERS)

Behind Covid vaccine, a couple with shared passion for cancer research

By Reuters | Reuters
UPDATED ON NOV 10, 2020 05:24 AM IST
Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing Covid-19 based on initial data from a large study.
Close
Pfizer company logo at the company's headquarters in New York. Pfizer is reporting a third-quarter profit of $2.19 billion.(AP)
Pfizer company logo at the company's headquarters in New York. Pfizer is reporting a third-quarter profit of $2.19 billion.(AP)

Pfizer says no Covid-19 vaccine data yet, could be week or more before it reports

By Reuters | Posted by Arpan Rai
PUBLISHED ON OCT 27, 2020 10:15 PM IST
Chief Executive Albert Bourla said after it has enough data for the analysis, it typically takes 5 to 7 days before the company can publicly release the data, meaning it is likely to happen after the election.
Close
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York (REUTERS/Carlo Allegri/File Photo)
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York (REUTERS/Carlo Allegri/File Photo)

Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan

By Reuters | Posted by Karan Manral | Tokyo
UPDATED ON OCT 20, 2020 01:22 PM IST
In a statement, the firms said the study will recruit 160 people aged from 20 to 85. Earlier, they had agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine, called mRNA, in the first half of 2021.
Close
Lonza, whose shares are up 60% this year, has a 10-year contract to supply ingredients to Moderna, including for up to 1 billion doses annually of Covid-19 vaccine.(REUTERS)
Lonza, whose shares are up 60% this year, has a 10-year contract to supply ingredients to Moderna, including for up to 1 billion doses annually of Covid-19 vaccine.(REUTERS)

Lonza confident of 2020 target for Moderna Covid-19 vaccine supply

By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 30, 2020 09:17 AM IST
New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps - to supply 300 million vaccine doses annually - should begin delivering by December.
Close
Without early doses that can bring outbreaks under control, many of these countries risk economic collapse that will push hundreds of millions of people back into poverty.(REUTERS)
Without early doses that can bring outbreaks under control, many of these countries risk economic collapse that will push hundreds of millions of people back into poverty.(REUTERS)

World Bank seeks board approval for $12 billion coronavirus vaccine financing plan

By Reuters| Posted by Susmita Pakrasi | Washington
PUBLISHED ON SEP 30, 2020 06:20 AM IST
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies.
Close
Drugmakers racing to develop a safe and effective coronavirus vaccine pledged in July to ensure their larger clinical trials would include diverse sets of volunteers.(REUTERS)
Drugmakers racing to develop a safe and effective coronavirus vaccine pledged in July to ensure their larger clinical trials would include diverse sets of volunteers.(REUTERS)

Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers

By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 13, 2020 10:04 AM IST
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
Close
A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe.(REUTERS)
A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe.(REUTERS)

Covid-19 vaccine developers plan pledge, Russian shot ‘passes early trial test’: All you need to know

By hindustantimes.com | Edited by Arpan Rai | Hindustan Times, New Delhi
UPDATED ON SEP 05, 2020 09:30 AM IST
Coronavirus disease outbreak has killed nearly 870,000 people and infected more than 26 million others worldwide as well as upended hundreds of millions of lives and wreaked havoc on the global economy.
Close
SHARE
Story Saved